Sartorius Stedim Biotech SA (DIM) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

EssilorLuxottica SA

bioMérieux SA

Guerbet SA

Sartorius Stedim Biotech SA

Amplitude Surgical SAS

Eurobio-Scientific SA

Nanobiotix SA

Crossject SA

Pixium Vision SA

Visiomed Group SA

Biosynex SA

Why is Sartorius Stedim Biotech SA ?

With ROE of 6.88%, it has a Very Expensive valuation with a 4.69 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 5.39%, its profits have risen by 45% ; the PEG ratio of the company is 1.5

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sartorius Stedim Biotech SA for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Sartorius Stedim Biotech SA

5.39%

1.19

36.88%

France CAC 40

8.73%

0.52

16.76%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.07%

EBIT Growth (5y)

2.90%

EBIT to Interest (avg)

7.14

Debt to EBITDA (avg)

1.85

Net Debt to Equity (avg)

0.52

Sales to Capital Employed (avg)

1.02

Tax Ratio

19.67%

Dividend Payout Ratio

38.14%

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

24.27%

ROE (avg)

21.32%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.69

EV to EBIT

43.21

EV to EBITDA

26.26

EV to Capital Employed

3.41

EV to Sales

7.22

PEG Ratio

1.52

Dividend Yield

1.03%

ROCE (Latest)

7.90%

ROE (Latest)

6.88%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Sartorius Stedim Biotech SA

Net Sales - Quarterly

At EUR 676 MM has Grown at -2.5 %

over average Net Sales of the previous four periods of EUR 694 MM

MOJO Watch

Near term sales trend is very positive

Net Sales (EUR MM)

Profit After Tax (PAT) - Quarterly

Highest at EUR nan MM.

in the last five periods

MOJO Watch

Near term PAT trend is positive

PAT (EUR MM)

Debt-Equity Ratio - Half Yearly

Lowest at 0.00 times

in the last five half yearly periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio- Half Yearly

Highest at times

in the last five half yearly periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio- Half Yearly

Highest at times

in the last five half yearly periods

MOJO Watch

Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Sartorius Stedim Biotech SA

Operating Profit to Interest - Quarterly

Lowest at 0.00 times and Fallen

in each of the last 5 periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest (EUR MM)

Operating Profit (PBDIT) - Quarterly

Lowest at EUR 0 MM. and Fallen

in each of the last 5 periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (EUR MM)

Operating Profit Margin - Quarterly

Lowest at 0.00% and Fallen

each quarter in the last five periods

MOJO Watch

Company's efficiency has deteriorated

Operating Profit to Sales (EUR MM)

Interest - Half-Yearly

At EUR 64.00 MM has Grown at 11.50%

over previous Year

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)

Earnings per Share (EPS) - Quarterly

Lowest at EUR 0.00

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (EUR)